Oramed Patent in Canada Allowed for Oral Delivery of Proteins
- Tuesday, April 7, 2020, 7:03
- Finance
- Add a comment
NEW YORK, April 7, 2020 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Canadian Patent Office has indicated its intent to…
About the Author
adminasapcorp has written 41546 stories on this site.